Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

Clinical trial NCT02883062 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02883062
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Invasive Breast Carcinoma Stage II Breast Cancer AJCC v6 and v7 Stage III Breast Cancer AJCC v7 Triple-Negative Breast Carcinoma

Start date: 2017-08-02
Primary completion: 2019-12-18
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.